肝脏和脾脏硬度在预测肝细胞癌切除术后复发中的作用
该前瞻性研究纳入175例适合肝切除的慢性肝病合并原发性肝细胞癌患者,随访至少30个月。多因素分析显示,脾脏硬度测量(SSM)是肝细胞癌晚期复发的唯一独立预测因素(HR 1.046,95%CI 1.020-1.073),且以SSM截断值70 kPa分组,晚期无复发生存率差异有统计学意义(p=0.0002)。
要点
- 脾脏硬度测量(SSM)是肝细胞癌切除术后晚期复发的唯一独立预测因素,HR 1.046(95%CI 1.020-1.073)。
- SSM截断值70 kPa分组间晚期无复发生存率差异有统计学意义(p=0.0002)。
- 早期复发多因素分析关联因素包括病毒病因、HCC分级3或4、切缘<1 cm及超出米兰标准。
核心结论
- 脾脏硬度测量似乎是肝细胞癌晚期复发的唯一预测因素,因其与肝病严重程度和门静脉高压直接相关,两者均参与癌变过程。
研究设计与样本
- 前瞻性研究,纳入175例适合肝切除的慢性肝病合并原发性肝细胞癌患者,随访至少30个月或直至肝细胞癌复发。
主要发现
- 早期肝细胞癌复发多因素分析关联因素包括病毒病因、肝细胞癌分级3或4、切缘<1 cm及超出米兰标准。
- 晚期肝细胞癌复发单因素分析关联因素包括食管静脉曲张(HR 3.321,95%CI 1.564-7.053)、脾脏长度(HR 3.123,95%CI 1.377-7.081)、血小板与脾脏长度比值<909(HR 2.170,95%CI 1.026-4.587)、肝脏硬度测量(HR 1.036,95%CI 1.005-1.067)、脾脏硬度测量(HR 1.046,95%CI 1.020-1.073)。
- 晚期肝细胞癌复发多因素分析仅脾脏硬度测量为独立关联因素(HR 1.046,95%CI 1.020-1.073)。
- 按脾脏硬度测量截断值70 kPa分组,晚期肝细胞癌无复发生存率差异有统计学意义(p=0.0002)。
关键数值与推荐
- 脾脏硬度测量预测晚期肝细胞癌复发的HR为1.046(95%CI 1.020-1.073)。
- 脾脏硬度测量截断值70 kPa用于分组比较晚期无复发生存率,p=0.0002。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is a frequent complication of liver disease. When feasible, hepatic resection is the first-choice therapy. However, tumor recurrence complicates at least 2/3 hepatic resections at 5 years. Early recurrences are mainly tumor or treatment-related, but predictors of late recurrences are undefined. We aimed to evaluate the factors related to HCC recurrence after curative resection, with liver and spleen stiffness measurement (LSM and SSM) as markers of severity and duration of the underlying liver disease. METHODS: We enrolled patients with chronic liver disease and primary HCC suitable for hepatic resection. We followed up patients for at least 30 months or until HCC recurrence. We performed uni- and multivariate analyses to evaluate the predictive role of tumor characteristics, laboratory data, LSM and SSM for both early and late recurrence of HCC. RESULTS: We prospectively enrolled 175 patients. Early HCC recurrence at multivariate analysis was associated with viral etiology, HCC grading (3 or 4), resection margins <1 cm and being beyond the Milan criteria. HCC late recurrence at univariate analysis was associated with esophageal varices (hazard ratio [HR] 3.321, 95% CI 1.564-7.053), spleen length (HR 3.123, 95% CI 1.377-7.081), platelet/spleen length ratio if <909 (HR 2.170, 95% CI 1.026-4.587), LSM (HR 1.036, 95% CI 1.005-1.067), SSM (HR 1.046, 95% CI 1.020-1.073). HCC late recurrence at multivariate analysis was independently associated only with SSM (HR 1.046, CI 1.020-1.073). Late HCC recurrence-free survival was significantly different according to the SSM cut-off of 70 kPa (p = 0.0002). CONCLUSIONS: SSM seems to be the only predictor of late HCC recurrence, since it is directly correlated with the degree of liver disease and portal hypertension, both of which are involved in carcinogenesis. LAY SUMMARY: The main result of this study is that spleen stiffness measurement, evaluated by transient elastography, seems to be the only predictor of the late recurrence of hepatocellular carcinoma, defined as recurrence after 24 months from liver resection. Indeed, spleen stiffness measurement is directly correlated with the degree of liver disease and portal hypertension, which are both involved in carcinogenesis.
引用
- Marasco G, Colecchia A, Colli A, et al. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection. J Hepatol. 2018. PMID: 30389551. doi:10.1016/j.jhep.2018.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。